EMERGENT BIOSOLUTIONS INC. Operating Lease, Expense
EMERGENT BIOSOLUTIONS INC. (EBS) reported Operating Lease, Expense of $200.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-08-09
- EMERGENT BIOSOLUTIONS INC. operating lease, expense for the quarter ending 2023-06-30 was $200.00K, a 33.33% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. operating lease, expense for the quarter ending 2023-03-31 was $200.00K, a 33.33% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. operating lease, expense for the quarter ending 2022-09-30 was $300.00K, a 0.00% change year-over-year.
- EMERGENT BIOSOLUTIONS INC. operating lease, expense for the quarter ending 2022-06-30 was $300.00K, a 0.00% change year-over-year.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month |
|---|---|---|---|
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-09 | $400.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-10 | ||
| 2022-09-30 | $300.00K 10-Q · filed 2022-11-09 | $600.00K derived: sum of 2 quarters · filed 2023-08-09 | $800.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $300.00K 10-Q · filed 2023-08-09 | $600.00K 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-10 | ||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-09 | $600.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.00M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-02 | $700.00K 10-Q · filed 2022-08-02 | |
| 2021-03-31 | $400.00K 10-Q · filed 2022-04-29 | ||
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-05 | $500.00K derived: sum of 2 quarters · filed 2021-11-05 | $800.00K 10-Q · filed 2021-11-05 |
| 2020-06-30 | $300.00K 10-Q · filed 2021-07-30 | $600.00K 10-Q · filed 2021-07-30 | |
| 2020-03-31 | $300.00K 10-Q · filed 2021-04-30 | ||
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-06 | $300.00K derived: sum of 2 quarters · filed 2020-11-06 | $400.00K 10-Q · filed 2020-11-06 |
| 2019-06-30 | $200.00K 10-Q · filed 2020-07-31 | $300.00K 10-Q · filed 2020-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |